Live
- They always want me to win, and now I feel lucky to have been offered a story like ‘Zebra’: Satyadev Kancharana
- ‘Democracy first, humanity first’: PM Modi in Guyana's parliament on two countries' similarities
- PKL Season 11: Telugu Titans register third straight win to top standings
- Is Pollution Contributing to Your COPD?
- NASA Unveils Underwater Robots for Exploring Jupiter's Moons
- Additional Central forces arrive in violence-hit Manipur
- AR Rahman and Saira Banu’s Divorce: Legal Insights into Common Issues in Bollywood Marriages
- 82.7 pc work completed in HPCL Rajasthan Refinery area: official
- Curfew relaxation extended in 5 Manipur districts on Friday
- Tab scam prompts Bengal govt to adopt caution over fund disbursement
Trudeau announces new plan for 'made-in-Canada' Covid-19 vaccine
Canadian Prime Minister Justin Trudeau
Canadian Prime Minister Justin Trudeau announced an additional C$214 million on 'made-in-Canada' vaccines as the country's coronavirus caseload has surpassed the 210,000 mark.
Ottawa: Canadian Prime Minister Justin Trudeau announced an additional C$214 million on 'made-in-Canada' vaccines as the country's coronavirus caseload has surpassed the 210,000 mark.
The additional fund included up to C$173 million for the Quebec biopharmaceutical Medicago Inc., including support to create a production facility in Quebec City, reports Xinhua news agency.
The ggovernment has signed an agreement with the Quebec company to supply up to 76 million doses of its vaccine once it is approved for use.
"This is about securing potential vaccines for Canadians while supporting good jobs in research," Trudeau said at a news conference in Ottawa on Friday.
Medicago is developing the vaccine in partnership with the British drug company GlaxoSmithKline.
The two companies said its pre-clinical results show the vaccine demonstrated a "high level of neutralizing antibodies following a single dose".
If the vaccine also performs well in a clinical setting, the companies are on track to make it available in the first half of 2021.
Medicago has said it has the manufacturing capacity to produce as many as 100 million doses in 2021.
Trudeau also announced that Precision NanoSystems, a Vancouver-based biotech company, will receive up to C$18.2 million for the development and testing of a vaccine candidate.
The Trudeau government has previously announced agreements with several companies to secure access to their Covid-19 vaccines should they prove successful and are approved for use in Canada.
These companies include AstraZeneca, Sanofi and GlaxoSmithKline, Johnson & Johnson, Novavax, Pfizer and Moderna.
The Prime Minister said he is hopeful that vaccines can be used in the early part of 2021.
Presently, Canada has 211,076 confirmed Covid-19 cases and 9,884 deaths, the Public Health Agency of Canada said on Friday.
The agency said that Canada's public health community has mobilized and collaborated like never before to stand up and sustain this response.
"We've all had to adapt and adjust as new information emerged, while at the same time navigating through the sea of uncertainties.
"Pandemics are whole of social events. That means the impacts extend across society, not only by affecting those who become ill but also by impacting the health, social and economic systems that affect our overall wellbeing.
"It also means that minimizing the pandemic's impact, both today and in the future, depends on all of our actions now," it added.
